Literature DB >> 19287843

Biofilms: microbes and disease.

Madhu Sharma Aparna1, Sarita Yadav.   

Abstract

Bacteria that attach to surface aggregate in a hydrated polymeric matrix of their own synthesis to form biofilms. These represent microbial societies with their own defense and communication system. Transitioning from acute to chronic infection is frequently associated with biofilm formation.Bacteria in biofilms are innately more resistant to antimicrobial agents. The presence of indwelling medical devices increases the risk for biofilm formation and subsequent infection. The current antibiotic therapies are of limited effectiveness in resolving biofilms infection.This review attempts to discuss the stages in biofilm formation, their pathogenic mechanisms, effect of antimicrobial agents, detection and eradication of the biofilms.

Mesh:

Substances:

Year:  2008        PMID: 19287843     DOI: 10.1590/s1413-86702008000600016

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  45 in total

Review 1.  Whether a novel drug delivery system can overcome the problem of biofilms in respiratory diseases?

Authors:  Kamal Dua; Shakti D Shukla; Rakesh K Tekade; Philip M Hansbro
Journal:  Drug Deliv Transl Res       Date:  2017-02       Impact factor: 4.617

Review 2.  Lessons learned and unlearned in periodontal microbiology.

Authors:  Ricardo Teles; Flavia Teles; Jorge Frias-Lopez; Bruce Paster; Anne Haffajee
Journal:  Periodontol 2000       Date:  2013-06       Impact factor: 7.589

3.  Prescription Opioids induce Gut Dysbiosis and Exacerbate Colitis in a Murine Model of Inflammatory Bowel Disease.

Authors:  Umakant Sharma; Rohini Khatri Olson; Federico Nicolas Erhart; Li Zhang; Jingjing Meng; Bradley Segura; Santanu Banerjee; Madhulika Sharma; Ashok Kumar Saluja; Sundaram Ramakrishnan; Maria T Abreu; Sabita Roy
Journal:  J Crohns Colitis       Date:  2020-07-09       Impact factor: 9.071

Review 4.  Nanotechnology-based drug delivery systems for control of microbial biofilms: a review.

Authors:  Matheus Aparecido Dos Santos Ramos; Patrícia Bento Da Silva; Larissa Spósito; Luciani Gaspar De Toledo; Bruna Vidal Bonifácio; Camila Fernanda Rodero; Karen Cristina Dos Santos; Marlus Chorilli; Taís Maria Bauab
Journal:  Int J Nanomedicine       Date:  2018-02-27

5.  Antimicrobial effect of anacardic acid-loaded zein nanoparticles loaded on Streptococcus mutans biofilms.

Authors:  Ramille Araújo Lima; Smyrna Luiza Ximenes de Souza; Lais Aragão Lima; Ana Larissa Ximenes Batista; Jennifer Thayanne Cavalcante de Araújo; Francisco Fábio Oliveira Sousa; Juliana Paiva Marques Lima Rolim; Tereza De Jesus Pinheiro Gomes Bandeira
Journal:  Braz J Microbiol       Date:  2020-06-19       Impact factor: 2.476

6.  Anaerobic metabolism occurs in the substratum of gonococcal biofilms and may be sustained in part by nitric oxide.

Authors:  Megan L Falsetta; Alastair G McEwan; Michael P Jennings; Michael A Apicella
Journal:  Infect Immun       Date:  2010-03-15       Impact factor: 3.441

Review 7.  Paraoxonases as potential antibiofilm agents: their relationship with quorum-sensing signals in Gram-negative bacteria.

Authors:  Jordi Camps; Isabel Pujol; Frederic Ballester; Jorge Joven; Josep M Simó
Journal:  Antimicrob Agents Chemother       Date:  2011-01-03       Impact factor: 5.191

8.  The role of activated acetate intermediates in the control of Escherichia coli biofilm amounts.

Authors:  Robert Mugabi; Daniel Sandgren; Megan Born; Ian Leith; Shelley M Horne; Birgit M Prüβ
Journal:  Webmedcentral       Date:  2012-07-18

9.  Investigation of bacterial biofilm in the human middle ear using optical coherence tomography and acoustic measurements.

Authors:  Cac T Nguyen; Sarah R Robinson; Woonggyu Jung; Michael A Novak; Stephen A Boppart; Jont B Allen
Journal:  Hear Res       Date:  2013-04-12       Impact factor: 3.208

10.  Antibiofilm activity of Fmoc-phenylalanine against Gram-positive and Gram-negative bacterial biofilms.

Authors:  Himanshi Singh; Avinash Gahane; Virender Singh; Shreya Ghosh; Ashwani Thakur
Journal:  J Antibiot (Tokyo)       Date:  2021-02-26       Impact factor: 2.649

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.